| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/03/2023 | ALPINE IMMUNE SCIENCES, INC. | NVLS | Grant | Stock Option (Right to buy) | 10k | $0.00 | $0 | | 01/03/2023 |
| 09/23/2022 | ALPINE IMMUNE SCIENCES, INC. | NVLS | Grant | Common Stock | 1.4M | $7.35 | $10M | See Footnote | 09/23/2022 |
| 09/23/2022 | ALPINE IMMUNE SCIENCES, INC. | NVLS | Grant | Common Stock | 639.5k | $7.35 | $4.7M | See Footnote | 09/23/2022 |
| 01/03/2022 | ALPINE IMMUNE SCIENCES, INC. | NVLS | Grant | Stock Option (Right to buy) | 10k | $0.00 | $0 | | 01/03/2022 |
| 09/28/2021 | Cue Health Inc. | HLTH | Conversion | Series C-1 Preferred Stock | 8.2M | $0.00 | $0 | See Footnote | 09/28/2021 |
| 09/28/2021 | Cue Health Inc. | HLTH | Grant | Common Stock | 788.4k | $12.80 | $10.1M | See Footnote | 09/28/2021 |
| 09/28/2021 | Cue Health Inc. | HLTH | Conversion | Common Stock | 8.2M | $0.00 | $0 | See Footnote | 09/28/2021 |
| 09/17/2021 | ALPINE IMMUNE SCIENCES, INC. | NVLS | Purchase | Common Stock | 1.5M | $9.40 | $14.5M | See Footnote | 09/17/2021 |
| 01/04/2021 | ALPINE IMMUNE SCIENCES, INC. | NVLS | Grant | Stock Option (Right to buy) | 7.6k | $0.00 | $0 | | 01/04/2021 |
| 01/02/2020 | ALPINE IMMUNE SCIENCES, INC. | NVLS | Grant | Stock Option (Right to buy) | 7.6k | $0.00 | $0 | | 01/02/2020 |
| 01/18/2019 | ALPINE IMMUNE SCIENCES, INC. | NVLS | Grant | | 1.2M | $12.74 | $15.7M | See Footnote | 01/18/2019 |
| 01/18/2019 | ALPINE IMMUNE SCIENCES, INC. | NVLS | Grant | | 3.2M | $5.37 | $17M | See Footnote | 01/18/2019 |
| 01/18/2019 | ALPINE IMMUNE SCIENCES, INC. | NVLS | Grant | Stock Option (right to buy) | 7.6k | $5.70 | $43.6k | | 01/18/2019 |
| 06/22/2018 | ARMO BioSciences, Inc. | ARMO | Other | Common Stock | 1.2M | $50.00 | $60.7M | By Decheng Capital China Life Sciences USD Fund II, L.P. | 06/22/2018 |
| 06/22/2018 | ARMO BioSciences, Inc. | ARMO | Disposition | Stock Option (right to buy) | 18k | $39.97 | $719.5k | | 06/22/2018 |
| 03/26/2018 | ARMO BioSciences, Inc. | ARMO | Grant | Stock Option (right to buy) | 18k | $39.97 | $719.5k | | 03/26/2018 |
| 01/30/2018 | ARMO BioSciences, Inc. | ARMO | Conversion | Series C-1 Convertible Preferred Stock | 1.2M | $0.00 | $0 | By Decheng Capital China Life Sciences USD Fund II, L.P. | 01/30/2018 |
| 01/30/2018 | ARMO BioSciences, Inc. | ARMO | Conversion | Common Stock | 1.2M | $0.00 | $0 | By Decheng Capital China Life Sciences USD Fund II, L.P. | 01/30/2018 |
| 01/01/2011 | China Biologic Products Holdings, Inc. | CBPO | Grant | Non-Qualified Stock Option | 30k | $16.39 | $491.7k | | 01/01/2011 |